Search research articles
Contact Us
Filters
Showing results (641-650 of 705) with videos related to
Page
of 71
Sort By:
Thyroid : Official Journal of the American Thyroid Association
|
May 28, 2013
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer
Frauke Bentzien, Marcus Zuzow, Nathan Heald, et al.
Science (New York, N.Y.)
|
March 29, 2008
Dynamics of Saturn's south polar vortex
Ulyana A Dyudina, Andrew P Ingersoll, Shawn P Ewald, et al.
Journal of Medicinal Chemistry
|
November 17, 2015
Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1H-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia
Michael J Genin, Ana B Bueno, Javier Agejas Francisco, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 2, 2003
A natural product ligand of the oxysterol receptor, liver X receptor
Kelli S Bramlett, Keith A Houck, Kristen M Borchert, et al.
Cancer Research
|
October 8, 2009
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases
Fawn Qian, Stefan Engst, Kyoko Yamaguchi, et al.
American Journal of Medical Genetics. Part A
|
February 25, 2020
Clinical features, molecular results, and management of 12 individuals with the rare arthrochalasia Ehlers-Danlos syndrome
Sandy Ayoub, Neeti Ghali, Chloe Angwin, et al.
Nature Communications
|
January 12, 2020
Reversible manipulation of the magnetic state in SrRuO<sub>3</sub> through electric-field controlled proton evolution
Zhuolu Li, Shengchun Shen, Zijun Tian, et al.
The Journal of Biological Chemistry
|
January 17, 2013
Genome-wide screen for modulation of hepatic apolipoprotein A-I (ApoA-I) secretion
Rebecca R Miles, William Perry, Joseph V Haas, et al.
Acta Neuropathologica Communications
|
October 20, 2023
Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits
R Keating Godfrey, Eric Alsop, Reed T Bjork, et al.
Molecular Cancer Therapeutics
|
September 20, 2011
Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth
F Michael Yakes, Jason Chen, Jenny Tan, et al.
Page
of 71
Search research articles
Search
Showing results (641-650 of 705) with videos related to
Sort By:
Page
of 71
Thyroid : Official Journal of the American Thyroid Association
|
May 28, 2013
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer
Frauke Bentzien, Marcus Zuzow, Nathan Heald, et al.
Science (New York, N.Y.)
|
March 29, 2008
Dynamics of Saturn's south polar vortex
Ulyana A Dyudina, Andrew P Ingersoll, Shawn P Ewald, et al.
Journal of Medicinal Chemistry
|
November 17, 2015
Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1H-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia
Michael J Genin, Ana B Bueno, Javier Agejas Francisco, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 2, 2003
A natural product ligand of the oxysterol receptor, liver X receptor
Kelli S Bramlett, Keith A Houck, Kristen M Borchert, et al.
Cancer Research
|
October 8, 2009
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases
Fawn Qian, Stefan Engst, Kyoko Yamaguchi, et al.
American Journal of Medical Genetics. Part A
|
February 25, 2020
Clinical features, molecular results, and management of 12 individuals with the rare arthrochalasia Ehlers-Danlos syndrome
Sandy Ayoub, Neeti Ghali, Chloe Angwin, et al.
Nature Communications
|
January 12, 2020
Reversible manipulation of the magnetic state in SrRuO<sub>3</sub> through electric-field controlled proton evolution
Zhuolu Li, Shengchun Shen, Zijun Tian, et al.
The Journal of Biological Chemistry
|
January 17, 2013
Genome-wide screen for modulation of hepatic apolipoprotein A-I (ApoA-I) secretion
Rebecca R Miles, William Perry, Joseph V Haas, et al.
Acta Neuropathologica Communications
|
October 20, 2023
Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits
R Keating Godfrey, Eric Alsop, Reed T Bjork, et al.
Molecular Cancer Therapeutics
|
September 20, 2011
Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth
F Michael Yakes, Jason Chen, Jenny Tan, et al.
Page
of 71